Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04633616 · ClinicalTrials.gov registry record · NA
Tailored Patient-Provider Communication (TPPC): Evaluating the Impact of TPPC in Dermatology Patients
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 134
- Enrollment target
NCT04633616 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 134 participants.
The verdict
NCT04633616, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
Study Summary
The impact of tailored patient-provider communication to improve clinical trial recruitment, patient knowledge, and patient engagement will be studied. Tailored patient-provider communication refers to the individualization of patient-provider communication using patients' preferred methods of communication. This involves the utilization of social messaging such as e-mail or text and/or social media platforms. These communication methods purport to and meet individual patient needs whilst ensuring that information is received and in a format that is familiar to each patient. The primary outcomes of the proposed research is to evaluate the impact of tailored patient-provider communication on patient response rates (speed and number), clinical trial recruitment rates, patient knowledge, and patient engagement.
Interventions
- OTHER Tailored Patient-Provider Communication
- OTHER Non-Tailored Patient-Provider Communication
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2020-11-16 |
| Est. Completion | 2022-01-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04633616
The ClinicalTrials.gov registry entry for NCT04633616 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tailored Patient-Provider Communication is the first listed.
NCT04633616 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04633616 about?
NCT04633616 is a clinical study titled "Tailored Patient-Provider Communication (TPPC): Evaluating the Impact of TPPC in Dermatology Patients". The impact of tailored patient-provider communication to improve clinical trial recruitment, patient knowledge, and patient engagement will be studied. Tailored patient-provider communication refers to the individualization of patient-provider communication using patients' preferred methods of commu...
What is the current status of trial NCT04633616?
This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2020-11-16. Estimated completion is 2022-01-19.
What interventions are being tested in trial NCT04633616?
The interventions under investigation include: Tailored Patient-Provider Communication (OTHER), Non-Tailored Patient-Provider Communication (OTHER).
Who is sponsoring clinical trial NCT04633616?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.